Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Extensive Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05224141
What this trial is testing

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

Who this might be right for
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC 460
Large-scale testing (Phase 3)WithdrawnNCT01563601
What this trial is testing

Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Cephalon
Testing effectiveness (Phase 2)Study completedNCT00887159
What this trial is testing

Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Ended earlyNCT01159327
What this trial is testing

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Who this might be right for
Small Cell Lung Cancer
National Cancer Center, Korea 13
Testing effectiveness (Phase 2)Ended earlyNCT01859741
What this trial is testing

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy

Who this might be right for
Stage IV Small Cell Lung Cancer
OncoMed Pharmaceuticals, Inc. 172
Testing effectiveness (Phase 2)Looking for participantsNCT07339059
What this trial is testing

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Bindu R Potugari 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04745689
What this trial is testing

Study of AZD2811 + Durvalumab in ES-SCLC

Who this might be right for
Small-Cell Lung Cancer
AstraZeneca 31
Testing effectiveness (Phase 2)Ended earlyNCT06939036
What this trial is testing

Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

Who this might be right for
Small Cell Lung Cancer Extensive StageMerkel Cell Carcinoma
Ariceum Therapeutics GmbH 2
Large-scale testing (Phase 3)UnknownNCT04254471
What this trial is testing

This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Haihe Biopharma Co., Ltd. 313
Testing effectiveness (Phase 2)Looking for participantsNCT06838208
What this trial is testing

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital 56
Testing effectiveness (Phase 2)Study completedNCT00079040
What this trial is testing

Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
National Cancer Institute (NCI) 65
Early research (Phase 1)WithdrawnNCT00006126
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

Who this might be right for
Breast CancerKidney CancerLung Cancer+2 more
Northwestern University
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT00286169
What this trial is testing

Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

Who this might be right for
Small-cell Lung Cancer
Sumitomo Pharma Co., Ltd. 130
Early research (Phase 1)WithdrawnNCT06427369
What this trial is testing

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerLung Non-Small Cell Carcinoma+2 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT04665856
What this trial is testing

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 123
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Testing effectiveness (Phase 2)Study completedNCT04622228
What this trial is testing

Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell Lung
Hoffmann-La Roche 56
Next Page